Login Register Cart 0
Generic placeholder image

Current Radiopharmaceuticals

Editor-in-Chief

ISSN (Print): 1874-4710
ISSN (Online): 1874-4729

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Clinical Trial

Fully Automated Methods for [18F]FDG and [18F]-NaF Productions Using Explora FDG4: Validation and Reliability of Multi-subsequent Preparations for Clinical Applications

Author(s): Eman Awad, Hatim Ali, James Lamb and Ehab Al-Momani*

Volume 15, Issue 4, 2022

Published on: 20 August, 2022

Page: [341 - 346] Pages: 6

DOI: 10.2174/1874471015666220518115244

Price: $65

conference banner
Abstract

Background: The worldwide usage of [18F]-sodium fluoride in clinical applications has increased the interest in the facility of its production. The development of a new automated method for multi-preparations of [18F]-NaF and [18F]FDG on an Explora FDG4 module is described. Explora FDG4 is one of the most widely used synthesizers for FDG production in daily routine use and is specifically designed to run up to four different productions with a single module. Therefore, slight modifications are carried out in order to increase the potential of the synthesizer to perform more radiopharmaceuticals.

Methods: A fully automated method for multi-preparations of [18F]-NaF and [18F]FDG using Explora FDG4 was developed. Slight modifications to the Explora’s hardware and software configuration were applied. A new elution vial for NaF preparation was installed and connected to the free position to MVP1. Quality control was carried out using the standard analytical methods applied for GMP production.

Results: This modification successfully provides preparation of [18F]-NaF without affecting the daily FDG production using one set preparation. [18F]-NaF was obtained in a high radiochemical yield (>90%, n=100) in 10 min total preparation time. The quality control results for both obtained products, FDG (RCP >95%) and NaF (RCP >98%), showed that the radiopharmaceuticals were in compliance with USP and Ph.Eur. specifications and compatible with clinical applications.

Conclusion: A rapid and simple method for multi preparations of [18F]-NaF and [18F]FDG using a single Explora module was designed. Yet, the chemistry module has the potential to generate more radiopharmaceuticals to decrease the cost of preparation of [18F]-NaF compared to the cassette-based synthesizers, reducing radiation exposure resulting from manual preparations and increasing the reproducibility of [18F]-NaF preparation.

Keywords: Radiosynthesis, [18F]-Sodium fluoride, automated synthesis, PET tracers, radiopharmaceuticals, Explora FDG4.

« Previous Next »
Graphical Abstract

[1]
Anderson, C.J.; Ferdani, R. Copper-64 radiopharmaceuticals for PET imaging of cancer: Advances in preclinical and clinical research. Cancer Biother. Radiopharm., 2009, 24(4), 379-393.
[http://dx.doi.org/10.1089/cbr.2009.0674] [PMID: 19694573]
[2]
Al-Ibraheem, A.; Buck, A.; Krause, B.J.; Scheidhauer, K.; Schwaiger, M. Clinical Applications of FDG PET and PET/CT in head and neck cancer. J. Oncol., 2009, 2009, 208725.
[http://dx.doi.org/10.1155/2009/208725] [PMID: 19707528]
[3]
Cherry, S.R.; Jones, T.; Karp, J.S.; Qi, J.; Moses, W.W.; Badawi, R.D. Total-body PET: Maximizing sensitivity to create new opportunities for clinical research and patient care. J. Nucl. Med., 2018, 59(1), 3-12.
[http://dx.doi.org/10.2967/jnumed.116.184028] [PMID: 28935835]
[4]
Alauddin, M.M. Positron emission tomography (PET) imaging with 18F-based radiotracers. J Nuc Med Mol Imag, 2012, 2(1), 55-76.
[5]
Miller, P.W.; Long, N.J.; Vilar, R.; Gee, A.D. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. Angew. Chem. Int. Ed. Engl., 2008, 47(47), 8998-9033.
[http://dx.doi.org/10.1002/anie.200800222] [PMID: 18988199]
[6]
Al-Momani, E.; Israel, I.; Buck, A.K.; Samnick, S. Improved synthesis of [¹Z F]FS-PTAD as a new tyrosine-specific prosthetic group for radiofluorination of biomolecules. Appl. Radiat. Isot., 2015, 104, 136-142.
[http://dx.doi.org/10.1016/j.apradiso.2015.06.021] [PMID: 26159662]
[7]
Disselhorst, J.A.; Brom, M.; Laverman, P.; Slump, C.H.; Boerman, O.C.; Oyen, W.J.; Gotthardt, M.; Visser, E.P. Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner. J. Nucl. Med., 2010, 51(4), 610-617.
[http://dx.doi.org/10.2967/jnumed.109.068858] [PMID: 20237025]
[8]
Blau, M.; Nagler, W.; Bender, M.A. Fluorine-18: A new isotope for bone scanning. J. Nucl. Med., 1962, 3, 332-334.
[PMID: 13869926]
[9]
Grant, F.D.; Fahey, F.H.; Packard, A.B.; Davis, R.T.; Alavi, A.; Treves, S.T. Skeletal PET with 18F-fluoride: Applying new technology to an old tracer. J. Nucl. Med., 2008, 49(1), 68-78.
[http://dx.doi.org/10.2967/jnumed.106.037200] [PMID: 18077529]
[10]
Czernin, J.; Satyamurthy, N.; Schiepers, C. Molecular mechanisms of bone 18F-NaF deposition. J. Nucl. Med., 2010, 51(12), 1826-1829.
[http://dx.doi.org/10.2967/jnumed.110.077933] [PMID: 21078790]
[11]
Nandy, S.K.; Rajan, M.G.R.; Soni, P.S.; Rangarajan, V. Production of sterile [F-18]NaF for skeletal PET imaging. Indian J. Nucl. Med., 2007, 281, 16-23.
[12]
Bastawrous, S.; Bhargava, P.; Behnia, F.; Djang, D.S.W.; Haseley, D.R. Newer PET application with an old tracer: Role of 18F-NaF skeletal PET/CT in oncologic practice. Radiographics, 2014, 34(5), 1295-1316.
[http://dx.doi.org/10.1148/rg.345130061] [PMID: 25208282]
[13]
Wang, M.; Zhang, Y.; Zhang, Y.; Yuan, H. Automated synthesis of 18F-FMISO using Explora FDG4 module. He Jishu/Nuclear Techniques, 2008, 31, 460-464.
[14]
Sun, L.Q.; Luo, A.Q.; Fujibayashi, Y. Automated Synthesis of 18F-Fluoroacetate Using Explora FDG4 Module. Proceedings of the 3rd International Conference on Bioinformatics and Biomedical Engineering, 2009, pp. 1-4.
[http://dx.doi.org/10.1109/ICBBE.2009.5162426]

Rights & Permissions Print Cite
Article Metrics
4
© 2024 Bentham Science Publishers | Privacy Policy